Biovica Secures SEK1 Million Oncology Study Work Order

MT Newswires · 3d ago
05:57 AM EDT, 07/20/2026 (MT Newswires) -- Biovica International (BIOVIC-B.ST) received its first work order under an expanded master services agreement with a global pharmaceutical customer for an oncology clinical study. The order, which is valued at 1 million kronor, covers the blood-based cancer monitoring company's DiviTum TKa testing services for a study expected to begin patient visits in September, according to a Monday release. Work is expected to run for two years.